PREEMPT Act

The PREEMPT Act directs the federal government to issue guidance and provide technical assistance to states regarding Medicaid coverage for preeclampsia screening and detection tests. This legislation aims to improve outcomes for pregnant women by promoting early detection and management of the condition, which is a leading cause of maternal and fetal deaths. Specifically, it requires the Secretary of Health and Human Services to outline best practices and determine which advanced biomarker tests can be covered under state Medicaid plans. The bill does not mandate that states cover these tests but instead establishes a framework for federal support to help states evaluate and implement such coverage.